Hensoldt reiterated its full-year 2024 guidance, maintaining targets for sales of €2.5-2.6 billion with an adjusted EBITDA margin of approximately 18%. The company continues to expect a book-to-bill ...

The company said its sales grew 11% from a year earlier to 944 million euros ($1.08 billion) in the first six months of 2025, ...

Fresh Hensoldt information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

PYRUKYND® (mitapivat) net revenues; ended second quarter with $1.3 billion dollars in cash, cash equivalents and marketable securitiesPYRUKYND sNDA for thalassemia under ...

JD.com, Inc. ("JD.com" or the "Company") (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service ...